Nitric oxide synthase and vascular dysfunction in sepsis: should we target nitric oxide synthase 1, nitric oxide synthase 2, both, or neither?
Department of Surgery; and, Department of Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Mitchell P
MP
Fink
D000818:Animals; D005260:Female; D006162:Guanylate Cyclase / Q000378:metabolism*; D007022:Hypotension / Q000209:etiology*; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology*; D018805:Sepsis / Q000150:complications*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D010656:Phenylephrine; D052248:Nitric Oxide Synthase Type I; D006162:Guanylate Cyclase; D009638:Norepinephrine